Skip to main content

Call for papers - Approaches to prevention of gynecological malignancies

Guest Editors

Federico Ferrari, MD, PhD, Department of Clinical and Experimental Sciences, University of Brescia, Italy
Andrea Giannini, MD, PhD, Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy

Submission Status: Open   |   Submission Deadline: 13 September 2024 

BMC Women's Health is calling for submissions to our Collection on Approaches to prevention of gynecological malignancies. 

This Collection aims to consolidate current knowledge, share innovative strategies, and promote interdisciplinary research focused on preventing gynecological tumors. Gynecological malignancies pose a significant health challenge for women worldwide. Despite advances in diagnosis and treatment, prevention remains a crucial aspect of the fight against these cancers. The urgency surrounding the prevention of gynecological tumors stems from their high incidence and mortality rates, with these issues constituting a major global health challenge. Many gynecological malignancies are preventable through measures such as early screening and vaccination, making prevention a critical avenue for reducing the burden of these diseases. These tumors profoundly impact women's health, contribute to healthcare disparities, and carry substantial economic and societal costs. 

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health and Well-Being and, SDG 5: Gender Equality.

Meet the Guest Editors

Back to top

Federico Ferrari, MD, PhD, Department of Clinical and Experimental Sciences, University of Brescia, Italy

Dr Ferarri is a clinician scientist in the field of gynecology oncology and cancer therapy and a lecturer as an Assistant Professor at the University of Brescia, Italy. His main research interests are the translational and clinical research setting in gynecologic oncology, in particular in all the aspects of prevention, diagnosis, surgical and medical treatment and follow-up. His particular research focus is oriented in surgical approaches for malignant disease, including minimally invasive surgery and the optimization of the patients’ management in this particular frame with a focus on ERAS programs and their interaction with long-term cancer outcomes. Regarding the lines of translational research, Dr Ferarri is involved in multicenter studies with active collaboration with national and international laboratories, in particular for the molecular classification of endometrial cancer and ovarian cancer genomic signature. At larger scales, he is committed to promoting international partnerships to enhance the evidence in my settings of activities and research.

Andrea Giannini, MD, PhD, Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy

Dr Giannini is a Specialist in Obstetrics and Gynecology at the University of Rome Sapienza, where he received a vote of 70/70 with honors. His research interests are in surgical and invasive medical procedures for gynecological tumors and diseases. He completed his PhD in Translational Medicine and Oncology and a degree in Medicine and Surgery, at the University of Rome Sapienza with a vote of 110/110 with honors. He successfully obtained his eligibility to practice Medicine in the Italian State Examination during the February 2015 session of the Registration in the Association of Physicians and Surgeons of Rome. Dr Giannini has coordinated and led multiple clinical trials assessing the efficacy and impact of treatments for gynecological malignancies. He also serves as an Editorial Board Member for the BMC Women’s Health journal.


About the Collection

BMC Women’s Health is calling for submissions to our Collection on Approaches to prevention of gynecological malignancies. 

Gynecological malignancies pose a significant health challenge for women worldwide. Despite advances in diagnosis and treatment, prevention remains a crucial aspect of the fight against these cancers. The urgency surrounding the prevention of gynecological tumors stems from their high incidence and mortality rates, with these issues constituting a major global health challenge. Many gynecological malignancies are preventable through measures such as early screening and vaccination, making prevention a critical avenue for reducing the burden of these diseases. These tumors profoundly impact women's health, contribute to healthcare disparities, and carry substantial economic and societal costs. 

This Collection aims to consolidate current knowledge, share innovative strategies, and promote interdisciplinary research focused on preventing gynecological tumors. We encourage researchers, clinicians, and experts in the field to contribute original research articles on topics including but not limited to advancements in screening, lifestyle interventions, vaccination programs, early detection methods, genetic predisposition assessment, and public health initiatives. 

This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being and, SDG 5: Gender Equality.

Image credit: Mariakray / stock.adobe.com 

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Approaches to prevention of gynecological malignancies" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.